Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Graft Rejection | 46 | 2024 | 4504 | 3.700 |
Why?
|
Transplantation Tolerance | 17 | 2025 | 641 | 3.080 |
Why?
|
Isoantigens | 16 | 2022 | 562 | 2.590 |
Why?
|
Transplantation, Homologous | 47 | 2024 | 4860 | 2.130 |
Why?
|
T-Lymphocytes | 42 | 2024 | 10263 | 2.010 |
Why?
|
Skin Transplantation | 19 | 2020 | 1097 | 1.970 |
Why?
|
Immune Tolerance | 25 | 2022 | 2328 | 1.440 |
Why?
|
Chimerism | 9 | 2022 | 154 | 1.410 |
Why?
|
Exosomes | 3 | 2021 | 417 | 1.390 |
Why?
|
Antigen Presentation | 13 | 2020 | 1250 | 1.160 |
Why?
|
Histocompatibility Antigens | 10 | 2024 | 479 | 1.160 |
Why?
|
Immunologic Memory | 11 | 2020 | 1377 | 1.150 |
Why?
|
Bone Marrow Transplantation | 15 | 2025 | 2730 | 1.060 |
Why?
|
Graft Survival | 21 | 2025 | 3904 | 1.060 |
Why?
|
Kidney Transplantation | 15 | 2025 | 4278 | 1.010 |
Why?
|
Antigen-Presenting Cells | 9 | 2024 | 960 | 1.010 |
Why?
|
Heart Transplantation | 18 | 2025 | 3306 | 0.980 |
Why?
|
Major Histocompatibility Complex | 13 | 2015 | 880 | 0.870 |
Why?
|
Corneal Transplantation | 7 | 2013 | 315 | 0.860 |
Why?
|
Histocompatibility Antigens Class II | 12 | 2010 | 1442 | 0.850 |
Why?
|
Interleukin-2 | 13 | 2016 | 1895 | 0.830 |
Why?
|
Macaca fascicularis | 14 | 2025 | 908 | 0.800 |
Why?
|
Mice, Inbred BALB C | 30 | 2020 | 6225 | 0.770 |
Why?
|
Autoantigens | 11 | 2018 | 890 | 0.720 |
Why?
|
CD8-Positive T-Lymphocytes | 13 | 2020 | 4652 | 0.640 |
Why?
|
Histocompatibility Antigens Class I | 12 | 2009 | 1362 | 0.640 |
Why?
|
Lymphocyte Depletion | 4 | 2015 | 606 | 0.630 |
Why?
|
CD4-Positive T-Lymphocytes | 17 | 2020 | 4410 | 0.610 |
Why?
|
Transplantation Immunology | 3 | 2011 | 540 | 0.570 |
Why?
|
Transplantation Chimera | 6 | 2015 | 609 | 0.550 |
Why?
|
H-2 Antigens | 4 | 2010 | 359 | 0.550 |
Why?
|
Lymphocyte Activation | 19 | 2013 | 5502 | 0.540 |
Why?
|
Animals | 95 | 2025 | 168939 | 0.530 |
Why?
|
Isoantibodies | 4 | 2015 | 681 | 0.520 |
Why?
|
Antigens, CD20 | 1 | 2015 | 199 | 0.480 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2016 | 266 | 0.460 |
Why?
|
Tissue Donors | 4 | 2025 | 2392 | 0.450 |
Why?
|
Transplantation Conditioning | 10 | 2016 | 1635 | 0.450 |
Why?
|
Dendritic Cells | 5 | 2013 | 2747 | 0.450 |
Why?
|
Peptides | 12 | 2001 | 4347 | 0.440 |
Why?
|
Receptors, Antigen, T-Cell | 7 | 2010 | 2571 | 0.430 |
Why?
|
Self Tolerance | 5 | 2006 | 122 | 0.430 |
Why?
|
Interferon-gamma | 17 | 2016 | 3157 | 0.430 |
Why?
|
T-Lymphocyte Subsets | 9 | 2014 | 1814 | 0.420 |
Why?
|
Lymphoid Tissue | 1 | 2014 | 445 | 0.420 |
Why?
|
Mice | 59 | 2021 | 81898 | 0.420 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 414 | 0.400 |
Why?
|
Free Radical Scavengers | 2 | 2006 | 213 | 0.380 |
Why?
|
Th1 Cells | 9 | 2009 | 1040 | 0.380 |
Why?
|
Autoimmunity | 8 | 2009 | 1361 | 0.370 |
Why?
|
Myosins | 3 | 2002 | 407 | 0.370 |
Why?
|
Transplants | 1 | 2013 | 209 | 0.360 |
Why?
|
Th2 Cells | 9 | 2009 | 1077 | 0.360 |
Why?
|
Mice, Inbred C57BL | 26 | 2020 | 22351 | 0.320 |
Why?
|
Immunomodulation | 1 | 2013 | 548 | 0.320 |
Why?
|
B-Lymphocytes | 4 | 2020 | 4787 | 0.310 |
Why?
|
T-Lymphocytes, Regulatory | 8 | 2025 | 3114 | 0.300 |
Why?
|
CD40 Ligand | 7 | 2013 | 528 | 0.290 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2000 | 827 | 0.290 |
Why?
|
Mice, Inbred CBA | 5 | 2010 | 439 | 0.280 |
Why?
|
Cardiac Myosins | 3 | 2018 | 128 | 0.280 |
Why?
|
Maternal-Fetal Exchange | 3 | 2020 | 453 | 0.270 |
Why?
|
Organ Transplantation | 1 | 2016 | 1172 | 0.250 |
Why?
|
Antibodies, Monoclonal | 8 | 2015 | 9244 | 0.240 |
Why?
|
Killer Cells, Natural | 2 | 2012 | 2209 | 0.240 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5753 | 0.240 |
Why?
|
Epitopes | 8 | 2002 | 2526 | 0.240 |
Why?
|
Mice, Inbred C3H | 3 | 2015 | 915 | 0.230 |
Why?
|
Bone Marrow Cells | 3 | 2013 | 2413 | 0.220 |
Why?
|
Manganese | 1 | 2006 | 393 | 0.220 |
Why?
|
Adaptation, Physiological | 2 | 2007 | 1312 | 0.220 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2505 | 0.200 |
Why?
|
Diphtheria Toxin | 2 | 2014 | 253 | 0.200 |
Why?
|
Peptide Fragments | 9 | 2003 | 5143 | 0.200 |
Why?
|
HLA Antigens | 2 | 1998 | 1339 | 0.190 |
Why?
|
Adaptive Immunity | 2 | 2020 | 734 | 0.180 |
Why?
|
Luminescent Measurements | 6 | 1991 | 342 | 0.180 |
Why?
|
Sarcoma, Experimental | 1 | 2000 | 116 | 0.170 |
Why?
|
Skin | 1 | 2013 | 4499 | 0.160 |
Why?
|
Amino Acid Sequence | 11 | 2014 | 13411 | 0.160 |
Why?
|
Mice, Transgenic | 5 | 2015 | 9546 | 0.160 |
Why?
|
Immunosuppressive Agents | 6 | 2015 | 4215 | 0.160 |
Why?
|
Molecular Sequence Data | 12 | 2014 | 17609 | 0.160 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2144 | 0.150 |
Why?
|
Swine, Miniature | 3 | 2016 | 972 | 0.150 |
Why?
|
Autoimmune Diseases | 4 | 2010 | 2255 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2006 | 2952 | 0.140 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2014 | 306 | 0.140 |
Why?
|
Ethylenediamines | 1 | 1997 | 57 | 0.140 |
Why?
|
Vimentin | 1 | 2018 | 257 | 0.140 |
Why?
|
Alopecia Areata | 1 | 1999 | 130 | 0.140 |
Why?
|
Interleukin-4 | 3 | 2011 | 1156 | 0.140 |
Why?
|
Models, Immunological | 2 | 2010 | 517 | 0.130 |
Why?
|
Kidney Function Tests | 2 | 2015 | 685 | 0.130 |
Why?
|
Lung Transplantation | 2 | 2015 | 1310 | 0.120 |
Why?
|
Graft Enhancement, Immunologic | 2 | 2013 | 58 | 0.120 |
Why?
|
Biological Factors | 1 | 1995 | 155 | 0.120 |
Why?
|
Antibodies, Neoplasm | 2 | 2006 | 282 | 0.120 |
Why?
|
Macrophage Activation | 2 | 1988 | 554 | 0.120 |
Why?
|
Interleukin-15 | 2 | 2012 | 186 | 0.120 |
Why?
|
Papio | 1 | 2016 | 672 | 0.110 |
Why?
|
Lymphocyte Transfusion | 1 | 2015 | 236 | 0.110 |
Why?
|
Organ Specificity | 2 | 2013 | 1968 | 0.110 |
Why?
|
Myocardium | 3 | 2012 | 4765 | 0.110 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 684 | 0.110 |
Why?
|
Swine | 4 | 2022 | 5985 | 0.110 |
Why?
|
Receptors, Fc | 2 | 1987 | 537 | 0.110 |
Why?
|
Organometallic Compounds | 1 | 1997 | 647 | 0.110 |
Why?
|
Mice, Inbred Strains | 6 | 2003 | 1767 | 0.110 |
Why?
|
Postoperative Complications | 2 | 2015 | 15831 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 220 | 0.110 |
Why?
|
Adolescent Psychiatry | 1 | 1995 | 165 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2020 | 3079 | 0.110 |
Why?
|
Psychophysiologic Disorders | 1 | 1995 | 222 | 0.100 |
Why?
|
Transplantation, Isogeneic | 3 | 2002 | 250 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2009 | 3803 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 4 | 2014 | 3738 | 0.100 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2015 | 747 | 0.100 |
Why?
|
Mice, Inbred A | 4 | 2004 | 245 | 0.100 |
Why?
|
Immunotoxins | 1 | 2012 | 175 | 0.100 |
Why?
|
Immunoconjugates | 2 | 2014 | 976 | 0.100 |
Why?
|
Radiation Chimera | 1 | 2011 | 216 | 0.090 |
Why?
|
Myocarditis | 1 | 1999 | 802 | 0.090 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 1997 | 820 | 0.090 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2011 | 56 | 0.090 |
Why?
|
School Health Services | 1 | 1995 | 388 | 0.090 |
Why?
|
Injections, Intraperitoneal | 3 | 2001 | 411 | 0.090 |
Why?
|
Maleimides | 1 | 2011 | 112 | 0.090 |
Why?
|
Thymus Gland | 3 | 2010 | 1266 | 0.090 |
Why?
|
Zymosan | 2 | 1988 | 134 | 0.090 |
Why?
|
Retina | 1 | 2001 | 2660 | 0.090 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2012 | 287 | 0.080 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 992 | 0.080 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2012 | 316 | 0.080 |
Why?
|
Flow Cytometry | 4 | 2014 | 5890 | 0.080 |
Why?
|
Adoptive Transfer | 2 | 2009 | 828 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2014 | 14473 | 0.080 |
Why?
|
beta Catenin | 2 | 2011 | 1048 | 0.080 |
Why?
|
Transduction, Genetic | 2 | 2010 | 899 | 0.080 |
Why?
|
Intracellular Space | 1 | 2010 | 198 | 0.080 |
Why?
|
Cells, Cultured | 6 | 2011 | 18986 | 0.080 |
Why?
|
Proteins | 2 | 2022 | 6002 | 0.080 |
Why?
|
Immunoglobulin G | 5 | 2003 | 4559 | 0.080 |
Why?
|
Chronic Disease | 5 | 2011 | 9358 | 0.080 |
Why?
|
Pulmonary Alveoli | 2 | 1988 | 665 | 0.070 |
Why?
|
Models, Animal | 3 | 2015 | 2121 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2016 | 2391 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2011 | 1337 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 892 | 0.070 |
Why?
|
Crosses, Genetic | 3 | 2003 | 751 | 0.070 |
Why?
|
Cytokines | 4 | 2009 | 7438 | 0.070 |
Why?
|
Retroviridae | 1 | 2010 | 846 | 0.070 |
Why?
|
Serine | 1 | 2011 | 828 | 0.070 |
Why?
|
Substrate Specificity | 1 | 2011 | 1750 | 0.070 |
Why?
|
Immunotherapy | 3 | 1999 | 4747 | 0.070 |
Why?
|
Immunization | 3 | 2011 | 1218 | 0.070 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 1627 | 0.070 |
Why?
|
Hepatovirus | 2 | 1997 | 45 | 0.070 |
Why?
|
Male | 21 | 2025 | 364154 | 0.070 |
Why?
|
Humans | 33 | 2024 | 766812 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2232 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1751 | 0.070 |
Why?
|
Female | 20 | 2020 | 396532 | 0.070 |
Why?
|
Catalase | 1 | 2006 | 215 | 0.070 |
Why?
|
Viral Hepatitis Vaccines | 2 | 1997 | 72 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2015 | 2060 | 0.060 |
Why?
|
Hepatitis A | 2 | 1997 | 126 | 0.060 |
Why?
|
Guinea Pigs | 3 | 1997 | 1309 | 0.060 |
Why?
|
Hypersensitivity, Delayed | 4 | 2011 | 491 | 0.060 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2005 | 54 | 0.060 |
Why?
|
Granulocytes | 1 | 1987 | 551 | 0.060 |
Why?
|
Phagocytosis | 1 | 2011 | 1526 | 0.060 |
Why?
|
Granuloma | 1 | 1987 | 329 | 0.060 |
Why?
|
Antibodies | 2 | 2003 | 2421 | 0.060 |
Why?
|
Catalysis | 1 | 2006 | 767 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1540 | 0.060 |
Why?
|
Pregnancy | 3 | 2020 | 30236 | 0.060 |
Why?
|
Lung Diseases | 1 | 2015 | 1940 | 0.060 |
Why?
|
Immunity | 1 | 1990 | 1002 | 0.060 |
Why?
|
Signal Transduction | 5 | 2011 | 23618 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 596 | 0.060 |
Why?
|
Free Radicals | 3 | 1989 | 237 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2014 | 2101 | 0.050 |
Why?
|
Graft vs Host Reaction | 1 | 2003 | 99 | 0.050 |
Why?
|
Lymphocytes | 1 | 2011 | 2606 | 0.050 |
Why?
|
Phosphorylation | 2 | 2011 | 8310 | 0.050 |
Why?
|
Antigens, Surface | 1 | 1987 | 1617 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1834 | 0.050 |
Why?
|
Maternal Behavior | 1 | 2005 | 307 | 0.050 |
Why?
|
Spleen | 3 | 2011 | 2295 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2006 | 1352 | 0.050 |
Why?
|
Autoantibodies | 1 | 2011 | 2115 | 0.050 |
Why?
|
Macrophages | 2 | 1988 | 5784 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 1 | 2015 | 3408 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2011 | 11657 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2001 | 511 | 0.050 |
Why?
|
Cornea | 3 | 2004 | 1316 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2002 | 268 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6507 | 0.050 |
Why?
|
Freund's Adjuvant | 1 | 2001 | 144 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4349 | 0.040 |
Why?
|
Polymorphism, Genetic | 2 | 2007 | 4249 | 0.040 |
Why?
|
Whole-Body Irradiation | 2 | 2014 | 438 | 0.040 |
Why?
|
Monocytes | 3 | 1994 | 2599 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2010 | 3401 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2003 | 839 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 609 | 0.040 |
Why?
|
Mice, Inbred DBA | 3 | 2011 | 624 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2006 | 1105 | 0.040 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 111 | 0.040 |
Why?
|
Blood Cells | 1 | 2002 | 309 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3723 | 0.040 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 492 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2006 | 1802 | 0.040 |
Why?
|
Minor Histocompatibility Loci | 1 | 1999 | 16 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 3079 | 0.040 |
Why?
|
Primates | 2 | 2015 | 519 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2198 | 0.040 |
Why?
|
Cancer Vaccines | 1 | 2006 | 1042 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6105 | 0.040 |
Why?
|
Histocompatibility Testing | 2 | 2015 | 726 | 0.040 |
Why?
|
Kinetics | 2 | 1999 | 6288 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 1998 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2006 | 1889 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 1999 | 403 | 0.040 |
Why?
|
Bone Marrow | 1 | 1987 | 2926 | 0.030 |
Why?
|
DNA, Complementary | 1 | 2000 | 1989 | 0.030 |
Why?
|
Mutation | 2 | 2006 | 30214 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2012 | 0.030 |
Why?
|
Membrane Glycoproteins | 3 | 2004 | 3702 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 1988 | 897 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2001 | 996 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2001 | 3468 | 0.030 |
Why?
|
Psychiatric Nursing | 1 | 1995 | 15 | 0.030 |
Why?
|
Lymphokines | 1 | 1998 | 924 | 0.030 |
Why?
|
Models, Biological | 1 | 2011 | 9464 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2000 | 4168 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5690 | 0.030 |
Why?
|
Horses | 1 | 2015 | 294 | 0.030 |
Why?
|
Cross Reactions | 1 | 1996 | 826 | 0.030 |
Why?
|
Receptors, IgG | 2 | 1987 | 562 | 0.030 |
Why?
|
Ligands | 1 | 2001 | 3274 | 0.030 |
Why?
|
Cell Transplantation | 1 | 1995 | 475 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 226 | 0.030 |
Why?
|
Professional Misconduct | 1 | 1994 | 72 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 1991 | 1417 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1646 | 0.030 |
Why?
|
Scientific Misconduct | 1 | 1994 | 77 | 0.030 |
Why?
|
Protein Binding | 2 | 2014 | 9326 | 0.030 |
Why?
|
Genes, MHC Class II | 1 | 1994 | 433 | 0.030 |
Why?
|
Inflammation | 2 | 2015 | 10863 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1994 | 705 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1991 | 826 | 0.020 |
Why?
|
Blood | 1 | 1994 | 598 | 0.020 |
Why?
|
Risk Factors | 3 | 2015 | 74889 | 0.020 |
Why?
|
Blood Group Incompatibility | 1 | 2011 | 134 | 0.020 |
Why?
|
Superoxides | 1 | 1991 | 388 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2127 | 0.020 |
Why?
|
Cell Division | 2 | 2002 | 4473 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 1989 | 102 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13644 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 4780 | 0.020 |
Why?
|
Rats | 2 | 2006 | 23717 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 412 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1991 | 546 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2012 | 10745 | 0.020 |
Why?
|
Mice, SCID | 2 | 2004 | 2626 | 0.020 |
Why?
|
Rosette Formation | 1 | 1987 | 152 | 0.020 |
Why?
|
Biopsy | 2 | 2012 | 6779 | 0.020 |
Why?
|
Lectins | 1 | 1989 | 490 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4618 | 0.020 |
Why?
|
Cell Line | 4 | 2014 | 15564 | 0.020 |
Why?
|
Acrylic Resins | 1 | 1987 | 131 | 0.020 |
Why?
|
Immunoglobulin Isotypes | 1 | 1987 | 158 | 0.020 |
Why?
|
HIV | 1 | 1994 | 1588 | 0.020 |
Why?
|
Base Sequence | 2 | 2014 | 12415 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7240 | 0.020 |
Why?
|
Pilot Projects | 2 | 2015 | 8728 | 0.020 |
Why?
|
Time Factors | 3 | 2004 | 40149 | 0.020 |
Why?
|
Gamma Rays | 1 | 1988 | 324 | 0.020 |
Why?
|
Gammaproteobacteria | 1 | 2006 | 28 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6965 | 0.020 |
Why?
|
Isotopes | 1 | 2006 | 125 | 0.020 |
Why?
|
Vaccines, Inactivated | 2 | 1997 | 186 | 0.020 |
Why?
|
Bromodeoxyuridine | 1 | 2006 | 310 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1997 | 3213 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2006 | 163 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2204 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6306 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2006 | 301 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1350 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1657 | 0.010 |
Why?
|
Kidney | 2 | 2011 | 7073 | 0.010 |
Why?
|
Clonal Anergy | 1 | 2004 | 169 | 0.010 |
Why?
|
Antigens, CD | 2 | 2004 | 4033 | 0.010 |
Why?
|
Busulfan | 1 | 2003 | 264 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 2003 | 1377 | 0.010 |
Why?
|
Immune Sera | 1 | 2001 | 605 | 0.010 |
Why?
|
Models, Genetic | 1 | 2011 | 3446 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 2001 | 250 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1987 | 1874 | 0.010 |
Why?
|
STAT4 Transcription Factor | 1 | 2000 | 94 | 0.010 |
Why?
|
Point Mutation | 1 | 2006 | 1592 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5749 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2006 | 1182 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2000 | 196 | 0.010 |
Why?
|
Tacrolimus | 1 | 2003 | 753 | 0.010 |
Why?
|
Transgenes | 1 | 2003 | 1014 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 13036 | 0.010 |
Why?
|
Adipocytes | 1 | 2006 | 1196 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10451 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 921 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2003 | 2677 | 0.010 |
Why?
|
Antibody Formation | 1 | 2002 | 1392 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 1676 | 0.010 |
Why?
|
Oxygen | 1 | 1989 | 4252 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 2062 | 0.010 |
Why?
|
Hepatitis A Vaccines | 1 | 1997 | 26 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 8045 | 0.010 |
Why?
|
Neoplasms | 1 | 2006 | 22350 | 0.010 |
Why?
|
Random Allocation | 1 | 2001 | 2394 | 0.010 |
Why?
|
Lung | 1 | 2015 | 10068 | 0.010 |
Why?
|
Fetus | 1 | 2003 | 1878 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2715 | 0.010 |
Why?
|
Immunogenetics | 1 | 1995 | 62 | 0.010 |
Why?
|
Consumer Product Safety | 1 | 1995 | 122 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4914 | 0.010 |
Why?
|
Phenotype | 1 | 2012 | 16722 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2006 | 11924 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2006 | 3582 | 0.010 |
Why?
|
France | 1 | 1994 | 496 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2002 | 2631 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2003 | 3115 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11062 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18329 | 0.010 |
Why?
|
DNA | 1 | 2006 | 7210 | 0.010 |
Why?
|
Ionomycin | 1 | 1991 | 109 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11218 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 12795 | 0.010 |
Why?
|
Trans-Activators | 1 | 2000 | 2856 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1251 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1994 | 1131 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1995 | 1733 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39312 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1991 | 347 | 0.010 |
Why?
|
Adolescent | 2 | 1995 | 88902 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1994 | 1612 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14653 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1991 | 1527 | 0.000 |
Why?
|
Disulfides | 1 | 1988 | 462 | 0.000 |
Why?
|
Molecular Weight | 1 | 1988 | 2168 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1729 | 0.000 |
Why?
|
Protein Processing, Post-Translational | 1 | 1993 | 1965 | 0.000 |
Why?
|
Binding Sites | 1 | 1993 | 6013 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20146 | 0.000 |
Why?
|
Staphylococcus aureus | 1 | 1991 | 1429 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9613 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1994 | 5795 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29959 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2002 | 65286 | 0.000 |
Why?
|
Middle Aged | 1 | 1995 | 223267 | 0.000 |
Why?
|
Adult | 1 | 1995 | 223305 | 0.000 |
Why?
|